KS

Kallabandi Sreekanth

Active Director Director DIN 10803493
DIN 10803493 First appointment Oct 2022 Primary industry General Business
Unlock full profile Investments · shareholding · contact details
Current companies 6 active board seats
Past companies –
Total affiliations 6 Since Oct 2022
Shareholding value •••• Premium profile

About Kallabandi Sreekanth

Data last updated:

Kallabandi Sreekanth has 4 years in corporate governance. Holds Director and Additional Director roles. Currently with 6 companies, including Claypond Capital Partners Private Limited and Manipal Health Systems Private Limited. Engaged in General Business, Healthcare. Contributes to corporate operations. The 3 current companies with reported revenue have a combined latest revenue of ₹431 Cr; the largest is Manipal Education And Medical Group India Private Limited at ₹341 Cr (FY 2025).

DIN 10803493
Primary Designation Director
First Appointment 19 Oct 2022
Oldest Company Age 27 yrs
Largest company Manipal Education And Medical Group India Private Limited · ₹341 Cr (FY 2025)
Combined revenue ₹431 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director09 Oct 20242004₹341 Cr (FY 2025)Active
Director18 Sep 20251999₹74.32 Cr (FY 2025)Active
Director09 Oct 20242024₹16.03 Cr (FY 2025)Active
Claypond Sports Private Limited U93190KA2026PTC216663
Director24 Feb 20262026–Active
Rbs Rugby Sports Private Limited U93190KA2025PTC200632
Additional Director19 Apr 20252025–Active
Partner19 Oct 20222020–Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Claypond Capital Partners Private Limited
Manipal Health Systems Private Limited
Rbs Rugby Sports Private Limited
Manipal Education And Medical Group India Private Limited
Premium access

Shareholding and investment profile for Kallabandi Sreekanth

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kallabandi Sreekanth

Kallabandi Sreekanth has 4 years in corporate governance. Holds Director and Additional Director roles. Currently with 6 companies, including Claypond Capital Partners Private Limited and Manipal Health Systems Private Limited. Engaged in General Business, Healthcare. Contributes to corporate operations. The 3 current companies with reported revenue have a combined latest revenue of ₹431 Cr; the largest is Manipal Education And Medical Group India Private Limited at ₹341 Cr (FY 2025).

Kallabandi Sreekanth is associated with 6 companies as Director and Additional Director, including Manipal Education And Medical Group India Private Limited (₹341 Cr), Manipal Health Systems Private Limited (₹74.32 Cr), Claypond Capital Partners Private Limited (₹16.03 Cr).

Kallabandi Sreekanth has expertise in General Business, Healthcare.

Kallabandi Sreekanth has 4 years in corporate governance.

By reported revenue, the largest current company of Kallabandi Sreekanth is Manipal Education And Medical Group India Private Limited, with revenue of ₹341 Cr (FY 2025).

The 3 current companies of Kallabandi Sreekanth that report revenue have a combined latest revenue of ₹431 Cr.

Kallabandi Sreekanth currently holds positions at 6 companies; the 5 largest by reported revenue are Manipal Education And Medical Group India Private Limited (₹341 Cr), Manipal Health Systems Private Limited (₹74.32 Cr), Claypond Capital Partners Private Limited (₹16.03 Cr), Claypond Sports Private Limited, Rbs Rugby Sports Private Limited.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available